Connect your AI

Pulse Biosciences, Inc. PLSE Earnings yield

Earnings yield at other companies

AbbottABT

3.5%-2.4pp

Johnson & JohnsonJNJ

3.6%-1.9pp

Boston ScientificBSX

3.8%+2.5pp

MedtronicMDT

4.6%+0.3pp

Merit Medical SystemsMMSI

3.4%+1.4pp

ITG

Integer HoldingsITGR

4.7%+2.8pp

Other financials

Income statement

Revenue$401.0K—

Gross profit$31.0K—

Operating income-$19.2M-6.1%

Net income-$18.6M-10.6%

EPS (diluted)-$0.49-2.1%

Balance sheet

Cash & equivalents$68.3M-42.7%

Total debt$7.2M-16.6%

Total equity$66.3M-44.0%

Total assets$81.6M-38.8%

Cash flow

Operating cash flow-$14.6M-7.9%

CapEx$33.0K-26.7%

Free cash flow-$14.6M-7.8%

Valuation

Market cap$1.77B+38.4%

Profitability

Gross margin-4,067.5%—

Operating margin-10,392.1%—

Net margin-9,929%—

FCF margin-7,390%—

Returns & leverage

Return on equity-80.7%+3.1pp

Debt / equity0.1×0.0×

Current ratio7.3×-8.3×

Where this comes from

Calculated from Pulse Biosciences, Inc.’s reported figures.

net income/market cap=-5.1%

Based on trailing twelve months.

The official record: Pulse Biosciences, Inc.’s 10-Q, filed May 14, 2026, on SEC EDGAR. View the filing →

Ask your AI about Pulse Biosciences, Inc.'s earnings yield.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Harbor at dusk

Questions, answered.

What is Pulse Biosciences, Inc.'s earnings yield?: Pulse Biosciences, Inc. (PLSE) reported earnings yield of -5.1% in Q1 2026.
How has Pulse Biosciences, Inc.'s earnings yield changed year-over-year?: Pulse Biosciences, Inc.'s earnings yield increased by 10.6% year-over-year, from -5.7% to -5.1%.
What is the long-term trend for Pulse Biosciences, Inc.'s earnings yield?: Over 5 years (2020 to 2025), Pulse Biosciences, Inc.'s earnings yield has grown at a -0.5% compound annual growth rate (CAGR), from -8% to -7.8%.
What does earnings yield mean?: Trailing-twelve-month net income divided by market capitalization at the quarter end — the inverse of the P/E ratio, expressed as a percentage.